The Global Cryo Electron Microscopy Market is projected to reach $1,525.20 million by 2028, from a value of $806.67 million in 2022, by registering a CAGR of 11.2% during the forecast period. Technological advancements in microscopy, favorable funding for research &development, and, increasing use of cryo-electron microscopes in biological science, material science, and other industries, are the major factors propelling the growth of the market. However, a lack of skilled professionals and, high costs are hampering the market growth. Moreover, the growth of nanotechnology is creating ample opportunities across the globe.
Recent Developments
In June 2022, ZEISS Microscopy partnered with LabCentral. ZEISS will provide access to key life science microscopy innovations for imaging and analysis solutions to researchers in LabCentral’s footprint in Cambridge, Massachusetts, USA.
In December 2021, Otsuka has announced that it entered into an exclusive commercial licensing agreement with Rebirthel Co., Ltd. (Rebirthel) for their technologies on CAR-T/TCR-T genetically engineered cell production using induced pluripotent stem (iPS) cells. The agreement covers multiple therapeutic areas worldwide.
In November 2021, Johnson & Johnson has entered into an agreement with the U.S. Government and Gavi, the Vaccine Alliance (Gavi), to enable access to its single-shot COVID-19 vaccine through a novel mechanism that will serve to protect the worlds most vulnerable people.
Competitive Landscape
ZEISS International, Thermo Fisher Scientific Inc., Structura Biotechnology Inc, Semilab Inc, Oxford Instruments, OPTIKA, Olympus Corporation, Nikon Corporation, Meiji Techno, Labomed, Inc, KEYENCE CORPORATION, JEOL Ltd, HORIBA Europe GmbH, Hitachi Ltd, Helmut Hund GmbHGatan, Inc, Johnson & Johnson, Creative Biostructure , Otsuka are some of the major players in the Global Cryo Electron Microscopy Market.
